Humana (HUM) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $46.72B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Healthcare Plans |
| Country | US | CEO | James A. Rechtin |
| IPO Date | 1981-12-31 | CAGR | 9.84% |
| Employees | 67,060 | Website | www.humana.com |
| Div. Yield | 0.81% | Payout Ratio | 34% |
| Buy Back Yield | 0.3% | Total Yield | 1.11% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $57.45B | P/E | 24.53 | Forward P/E | 23.48 | PEG | 1.34 |
| P/S | 0.36 | P/B | 2.77 | P/CF | 363.01 | P/FCF | -120.31 |
| Sales | $145.68B | Sales 1Y | 18.33% | Sales 3Y | 47.56% | Sales 5Y | 81.08% |
| EPS | $15.86 | EPS 1Y | -18.96% | EPS 3Y | -60.6% | EPS 5Y | -44.19% |
| Sales QoQ | 3.07% | EPS QoQ | -41.81% | Sales QoQ Avg | 6.35% | EPS QoQ Avg | -215.66% |
| Gross Margin | 13.65% | Operating Margin | 1.39% | Profit Margin | 0.88% | ROCE | 5.91% |
| ROA | 2% | ROE | 7% | Altman Z Score | 4.52 | Piotroski Score | 7 |
| Current Ratio | 1.74 | Quick Ratio | 1.74 | Cash Ratio | 0.3 | Op. CF Ratio | -0.02 |
| Debt/Equity | 0.74 | Debt/Assets | 0.25 | Lt Debt/Equity | 0.62 | Lt Debt/Cap. | 0.38 |
| Intrst Cov. | 2.87 | Inventory Turnover | — | Asset Turnover | 2.55 | Receivables Turnover | 25.58 |
| Enterprise Value | $57.45B | P/E Ratio | 24.53 |
| Forward P/E | 23.48 | PEG Ratio | 1.34 |
| P/S Ratio | 0.36 | P/B Ratio | 2.77 |
| P/CF Ratio | 363.01 | P/FCF Ratio | -120.31 |
| EPS | $15.86 | EPS Growth 1Y | -18.96% |
| EPS Growth 3Y | -60.6% | EPS Growth 5Y | -44.19% |
| Revenue Growth 1Y | 18.33% | Gross Margin | 0.14% |
| Operating Margin | 0.01% | Profit Margin | 0.01% |
| ROE | 0.07% | ROA | 0.02% |
| ROCE | 0.06% | Current Ratio | 1.74 |
| Quick Ratio | 1.74 | Cash Ratio | 0.3 |
| Debt/Equity | 0.74 | Interest Coverage | 2.87 |
| Altman Z Score | 4.52 | Piotroski Score | 7 |
Humana (HUM) valuation & financials
Humana (HUM) has a market capitalization of $46.72B and trades at a price-to-earnings ratio of 24.5. It operates in the Healthcare sector (Medical - Healthcare Plans).
Humana's revenue grew +18.3% over the last year.
Humana's next earnings report is scheduled for November 4, 2026 before market open; analysts estimate EPS of $-0.90. Check the earnings calendar to see all companies reporting this week.
Humana (HUM) — frequently asked questions
When does Humana (HUM) report earnings next?
Humana is expected to report earnings on November 4, 2026 before market open. Analysts estimate EPS of $-0.90.
What is Humana's market cap?
Humana (HUM) has a market capitalization of $46.72B.
What is HUM's P/E ratio?
Humana trades at a price-to-earnings ratio of 24.5, with trailing twelve-month EPS of $15.86.
How fast is Humana growing?
Humana's revenue grew +18.3% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)